Transcriptomics

Dataset Information

0

A single administration of hIL-7-hyFc induces long-lasting T-cell expansion with maintained effector functions and TCR repertoire diversity


ABSTRACT: Interleukin-7 (IL-7) is an essential cytokine for T-cell homeostatic proliferation and maintenance. Clinical studies have shown the potential benefits of IL-7 therapy in various diseases associated with lymphopenia. However, the kinetics of the T-cell response to a single administration of IL-7 in humans have not been fully elucidated. Here, we investigated the effects of Fc-fused long-acting recombinant human IL-7 (hIL-7-hyFc, efineptakin alfa) on lymphocytes in healthy adults after a single subcutaneous or intramuscular administration. Administration of hIL-7-hyFc increased the CD8+ and CD4+ T-cell numbers up to 2.5-fold, with corresponding upregulation of Ki-67 and Bcl-2 expression, peaking at day 3 or 7. Regulatory T cells did not expand. Among CD8+ and CD4+ T cells, all T-cell subsets (TN, TEM, TCM, TEMRA, and TSCM) increased for 56 days. The TCR repertoire diversity of naïve CD8+ and CD4+ T cells was increased by hIL-7-hyFc, while the memory T-cell subsets did not differ between D56 and D0. Transcriptomic analysis revealed that hIL-7-hyFc induced robust T-cell expansion without changes in gene expression profiles associated with T-cell functions or genes related to T-cell exhaustion, senescence, and anergy. The effector functions of antigen-specific CD8+ T cells were preserved after hIL-7-hyFc administration. Our results suggest that hIL-7-hyFc administration induced a sustained increase in the numbers of CD8+ and CD4+ T cells, but not regulatory T cells, without qualitative changes. These results support the potential of hIL-7-hyFc as a treatment for patients with compromised T-cell immunity or as a vaccine adjuvant.

ORGANISM(S): Homo sapiens

PROVIDER: GSE214137 | GEO | 2022/10/02

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-01-26 | PXD044740 | Pride
2021-08-18 | PXD021264 | Pride
2018-09-01 | E-MTAB-6648 | biostudies-arrayexpress
2015-09-01 | E-GEOD-61195 | biostudies-arrayexpress
2013-11-01 | E-GEOD-50149 | biostudies-arrayexpress
2020-10-14 | MTBLS2087 | MetaboLights
2016-06-01 | E-GEOD-73118 | biostudies-arrayexpress
2013-11-01 | GSE50149 | GEO
2016-07-01 | E-GEOD-73001 | biostudies-arrayexpress
2021-01-28 | GSE140250 | GEO